• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种机器学习算法以分类具有未知胎儿效应的药物。

Development of A Machine Learning Algorithm to Classify Drugs Of Unknown Fetal Effect.

机构信息

Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, USA.

Institute for Biomedical Informatics, University of Pennsylvania, Philadelphia, USA.

出版信息

Sci Rep. 2017 Oct 9;7(1):12839. doi: 10.1038/s41598-017-12943-x.

DOI:10.1038/s41598-017-12943-x
PMID:28993650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5634437/
Abstract

Many drugs commonly prescribed during pregnancy lack a fetal safety recommendation - called FDA 'category C' drugs. This study aims to classify these drugs into harmful and safe categories using knowledge gained from chemoinformatics (i.e., pharmacological similarity with drugs of known fetal effect) and empirical data (i.e., derived from Electronic Health Records). Our fetal loss cohort contains 14,922 affected and 33,043 unaffected pregnancies and our congenital anomalies cohort contains 5,658 affected and 31,240 unaffected infants. We trained a random forest to classify drugs of unknown pregnancy class into harmful or safe categories, focusing on two distinct outcomes: fetal loss and congenital anomalies. Our models achieved an out-of-bag accuracy of 91% for fetal loss and 87% for congenital anomalies outperforming null models. Fifty-seven 'category C' medications were classified as harmful for fetal loss and eleven for congenital anomalies. This includes medications with documented harmful effects, including naproxen, ibuprofen and rubella live vaccine. We also identified several novel drugs, e.g., haloperidol, that increased the risk of fetal loss. Our approach provides important information on the harmfulness of 'category C' drugs. This is needed, as no FDA recommendation exists for these drugs' fetal safety.

摘要

许多在怀孕期间常用的药物缺乏胎儿安全性建议——被称为 FDA“类别 C”药物。本研究旨在使用化学生物学(即与已知具有胎儿效应的药物的药理学相似性)和经验数据(即源自电子健康记录)将这些药物分为有害和安全两类。我们的胎儿丢失队列包含 14922 例受影响和 33043 例未受影响的妊娠,我们的先天畸形队列包含 5658 例受影响和 31240 例未受影响的婴儿。我们训练了一个随机森林来将未知妊娠类别的药物分为有害或安全类别,重点关注两个不同的结果:胎儿丢失和先天畸形。我们的模型对胎儿丢失的出袋准确率为 91%,对先天畸形的准确率为 87%,优于空模型。五十七种“类别 C”药物被归类为对胎儿丢失有害,十一种对先天畸形有害。这包括有记录的有害影响的药物,如萘普生、布洛芬和风疹活疫苗。我们还发现了几种新的药物,如氟哌啶醇,会增加胎儿丢失的风险。我们的方法提供了有关“类别 C”药物危害性的重要信息。由于这些药物的胎儿安全性没有 FDA 建议,因此这是必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5634437/a031b35f3110/41598_2017_12943_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5634437/8658b7f871d8/41598_2017_12943_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5634437/23720bff0241/41598_2017_12943_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5634437/2302d236d9de/41598_2017_12943_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5634437/87d6eaa0a896/41598_2017_12943_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5634437/8a208dbdf187/41598_2017_12943_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5634437/a031b35f3110/41598_2017_12943_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5634437/8658b7f871d8/41598_2017_12943_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5634437/23720bff0241/41598_2017_12943_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5634437/2302d236d9de/41598_2017_12943_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5634437/87d6eaa0a896/41598_2017_12943_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5634437/8a208dbdf187/41598_2017_12943_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5634437/a031b35f3110/41598_2017_12943_Fig6_HTML.jpg

相似文献

1
Development of A Machine Learning Algorithm to Classify Drugs Of Unknown Fetal Effect.开发一种机器学习算法以分类具有未知胎儿效应的药物。
Sci Rep. 2017 Oct 9;7(1):12839. doi: 10.1038/s41598-017-12943-x.
2
Drug use during pregnancy and breast-feeding. A classification system for drug information.孕期及哺乳期用药。药物信息分类系统。
Acta Obstet Gynecol Scand Suppl. 1984;126:1-55. doi: 10.3109/00016348409156383.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Fetal health status prediction based on maternal clinical history using machine learning techniques.基于机器学习技术的基于产妇临床史的胎儿健康状况预测。
Comput Methods Programs Biomed. 2018 Sep;163:87-100. doi: 10.1016/j.cmpb.2018.06.010. Epub 2018 Jun 14.
5
Drugs during pregnancy: an issue of risk classification and information to prescribers.孕期用药:风险分类及向开处方者提供信息的问题。
Drug Saf. 1996 Feb;14(2):69-77. doi: 10.2165/00002018-199614020-00001.
6
Risk classification systems for drug use during pregnancy: are they a reliable source of information?孕期药物使用风险分类系统:它们是可靠的信息来源吗?
Drug Saf. 2000 Sep;23(3):245-53. doi: 10.2165/00002018-200023030-00006.
7
Machine learning algorithms to predict early pregnancy loss after in vitro fertilization-embryo transfer with fetal heart rate as a strong predictor.以胎儿心率作为强预测指标,用于预测体外受精-胚胎移植后早期妊娠丢失的机器学习算法。
Comput Methods Programs Biomed. 2020 Nov;196:105624. doi: 10.1016/j.cmpb.2020.105624. Epub 2020 Jun 25.
8
Changing paradigms in detecting rare adverse drug reactions: from disproportionality analysis, old and new, to machine learning.改变检测罕见药物不良反应的范式:从传统的不成比例分析,到新的机器学习方法。
Expert Opin Drug Saf. 2022 Oct;21(10):1235-1238. doi: 10.1080/14740338.2022.2131770. Epub 2022 Oct 4.
9
Human experiences related to adverse drug reactions to the fetus or neonate from some maternally administered drugs.人类因母亲使用某些药物而对胎儿或新生儿产生药物不良反应的经历。
Adv Exp Med Biol. 1972;27:17-30. doi: 10.1007/978-1-4684-3219-0_3.
10
PregTox: A Resource of Knowledge about Drug Fetal Toxicity.PregTox:药物胚胎毒性知识资源
Biomed Res Int. 2022 Apr 16;2022:4284146. doi: 10.1155/2022/4284146. eCollection 2022.

引用本文的文献

1
Applying AI to Structured Real-World Data for Pharmacovigilance Purposes: Scoping Review.将人工智能应用于结构化真实世界数据以用于药物警戒目的:范围综述。
J Med Internet Res. 2024 Dec 30;26:e57824. doi: 10.2196/57824.
2
Enhancing inclusivity in clinical trials: Model-informed drug development for pregnant individuals in the era of personalized medicine.提高临床试验的包容性:个性化医疗时代针对孕妇的模型指导药物研发。
CPT Pharmacometrics Syst Pharmacol. 2024 Nov;13(11):1824-1829. doi: 10.1002/psp4.13218. Epub 2024 Aug 18.
3
Effects of gestational haloperidol exposure on mRNA expressions related to glutamate and GABA receptors in offspring.

本文引用的文献

1
Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study.孕期使用抗生素与重大先天性畸形风险:基于人群的队列研究。
Br J Clin Pharmacol. 2017 Nov;83(11):2557-2571. doi: 10.1111/bcp.13364. Epub 2017 Aug 11.
2
A longitudinal analysis of data quality in a large pediatric data research network.大型儿科数据研究网络中数据质量的纵向分析。
J Am Med Inform Assoc. 2017 Nov 1;24(6):1072-1079. doi: 10.1093/jamia/ocx033.
3
Movement patterns in women at risk for perinatal depression: use of a mood-monitoring mobile application in pregnancy.
孕期暴露于氟哌啶醇对子代中与谷氨酸和γ-氨基丁酸受体相关的mRNA表达的影响。
IBRO Neurosci Rep. 2023 Oct 2;15:281-286. doi: 10.1016/j.ibneur.2023.09.012. eCollection 2023 Dec.
4
Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review.利用电子健康记录数据识别药物安全信号:范围综述。
Drug Saf. 2023 Aug;46(8):725-742. doi: 10.1007/s40264-023-01325-0. Epub 2023 Jun 20.
5
Using Machine Learning to Predict Complications in Pregnancy: A Systematic Review.使用机器学习预测妊娠并发症:一项系统综述。
Front Bioeng Biotechnol. 2022 Jan 19;9:780389. doi: 10.3389/fbioe.2021.780389. eCollection 2021.
6
Data-Driven Modeling of Pregnancy-Related Complications.基于数据的妊娠并发症建模。
Trends Mol Med. 2021 Aug;27(8):762-776. doi: 10.1016/j.molmed.2021.01.007. Epub 2021 Feb 8.
7
Engineered tissues and strategies to overcome challenges in drug development.工程化组织和策略以克服药物开发中的挑战。
Adv Drug Deliv Rev. 2020;158:116-139. doi: 10.1016/j.addr.2020.09.012. Epub 2020 Sep 26.
8
Machine Learning Within Studies of Early-Life Environmental Exposures and Child Health: Review of the Current Literature and Discussion of Next Steps.机器学习在早期生活环境暴露与儿童健康研究中的应用:当前文献综述及下一步讨论。
Curr Environ Health Rep. 2020 Sep;7(3):170-184. doi: 10.1007/s40572-020-00282-5.
9
Machine learning on drug-specific data to predict small molecule teratogenicity.基于药物特异性数据的机器学习预测小分子致畸性。
Reprod Toxicol. 2020 Aug;95:148-158. doi: 10.1016/j.reprotox.2020.05.004. Epub 2020 May 16.
10
Enabling pregnant women and their physicians to make informed medication decisions using artificial intelligence.利用人工智能让孕妇及其医生能够做出明智的用药决策。
J Pharmacokinet Pharmacodyn. 2020 Aug;47(4):305-318. doi: 10.1007/s10928-020-09685-1. Epub 2020 Apr 11.
有围产期抑郁症风险的女性的运动模式:孕期使用情绪监测移动应用程序
J Am Med Inform Assoc. 2017 Jul 1;24(4):746-753. doi: 10.1093/jamia/ocx005.
4
Effect of psychotropic drug treatment on sterol metabolism.精神药物治疗对甾醇代谢的影响。
Schizophr Res. 2017 Sep;187:74-81. doi: 10.1016/j.schres.2017.02.001. Epub 2017 Feb 12.
5
A mixed methods study of clinical information availability in obstetric triage and prenatal offices.一项关于产科分诊和产前检查科室临床信息可及性的混合方法研究。
J Am Med Inform Assoc. 2017 Apr 1;24(e1):e87-e94. doi: 10.1093/jamia/ocw113.
6
Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review.探究7-脱氢胆固醇还原酶途径以阐明药物的非靶向产前效应:一项系统评价
Pharmacogenomics J. 2016 Oct;16(5):411-29. doi: 10.1038/tpj.2016.48. Epub 2016 Jul 12.
7
Participatory design of ehealth solutions for women from vulnerable populations with perinatal depression.针对患有围产期抑郁症的弱势群体妇女的电子健康解决方案的参与式设计。
J Am Med Inform Assoc. 2016 Jan;23(1):105-9. doi: 10.1093/jamia/ocv109. Epub 2015 Sep 5.
8
Measuring Gestational Age in Vital Statistics Data: Transitioning to the Obstetric Estimate.生命统计数据中孕周的测量:向产科估计值的转变。
Natl Vital Stat Rep. 2015 Jun 1;64(5):1-20.
9
Birth month affects lifetime disease risk: a phenome-wide method.出生月份影响一生的疾病风险:一种全表型组方法。
J Am Med Inform Assoc. 2015 Sep;22(5):1042-53. doi: 10.1093/jamia/ocv046. Epub 2015 Jun 2.
10
Safety of cosmetic dermatologic procedures during pregnancy.妊娠期美容皮肤科操作的安全性。
Dermatol Surg. 2013 Nov;39(11):1573-86. doi: 10.1111/dsu.12322. Epub 2013 Oct 29.